Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 16, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • AstraZeneca

Tag: AstraZeneca

  • BiotechToday
  • World

AstraZeneca Vaccine: Successful Clinical Trial results

BioTech Today August 29, 2021August 29, 2021 1

Aqsa, Jamia Millia Islamia Vaccination is the quickest and most effective way to protect against infectious diseases. It helps your body to recognize the specific pathogen and generate an immune response against it. Different vaccines have been developed against the causative agent of the current Covid-19 pandemic. These vaccines have undergone successful clinical trials and […]

Read More
  • BiotechToday
  • World

Longer gap between vaccine doses: Effective or not?

BioTech Today July 8, 2021July 7, 2021

Anjali Kumari, IILM College of Engineering and Technology Longer gap (up to 45 weeks) between the Covid-19 vaccines may increase the immune response. According to a new study from the University of Oxford in the United Kingdom, it has been stated that a gap of up to 45 weeks between the first and second doses […]

Read More
  • BiotechToday
  • World

Decreased efficacy of AstraZeneca vaccines on S. African strains

bioxone February 11, 2021February 11, 2021 1

Rohit Bhattacharjee, Amity University, Kolkata. The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain. The University of Witwatersrand, Johannesburg, which conducted the in which they stated that the vaccine provided minimal protection against mild-moderate COVID-19 infection. The data, which has not yet undergone peer review appeared to confirm the theoretical […]

Read More
  • BiotechToday
  • India

Tata to launch Moderna COVID-19 vaccine in India

bioxone January 28, 2021January 28, 2021 1

Srilagna Sarkar, Amity University Kolkata Tata Medical and Diagnostics are in talks to team up with India’s Council of Scientific and Industrial Research in order to carry out Moderna’s vaccine candidate in India. Tata Group’s healthcare venture is said to have started the initial discussion with Moderna Inc on partnership in launching its COVID-19 vaccine […]

Read More
  • Biotechnopedia
  • DNA-Tales

Covid Update- Doom of the New Coronavirus Strain

bioxone January 22, 2021January 22, 2021 1

Ankita Chattopadhyay, Amity University Kolkata Previously, COVID19 was associated with the onset of numerous symptoms that ranged from mild to moderate severity, starting from cough and fever to complete loss of movement in some cases. Unusual numbers of people from all over the world started showing different sorts of symptoms with different severities, at some […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

bioxone September 12, 2020September 12, 2020

-Anuska Sen, Team bioXone On 10th September 2020, that is 2 days back, Team BioXone had covered a piece of news stating the pause of the Covid-19 vaccine of AstraZeneca by Serum Institute. Today, it has been reported that once again, the trials for AstraZeneca’s Covid-19 vaccine has been successfully resumed. The one reason that […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials put on hold by Serum Institute

bioxone September 10, 2020September 10, 2020

–Anuska Sen, Team bioXone While the entire nation unanimously waits for India’s Covid-19 vaccine, there are various drawbacks and negativities regarding the vaccine that keeps on upsetting the world, particularly Indians. However, another disheartening news has been reported today. AstraZeneca’s Covid-19 vaccine has been paused by its partner, the Serum Institute of India. Earlier this […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy